Natural Killer Cells Modulation in Hematological Malignancies

Hematological malignancies (HM) treatment improved over the last years resulting in increased achievement of complete or partial remission, but unfortunately high relapse rates are still observed, due to remaining minimal residual disease. Therefore, sustainment of long-term remission is crucial, us...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Baier, Céline, Fino, Aurore, Sanchez, Carole, Farnault, Laure, Rihet, Pascal, Kahn-Perlès, Brigitte, Costello, Régis T.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2013
Gaiak:
Immunology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3867693/
https://ncbi.nlm.nih.gov/pubmed/24391641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2013.00459
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak